1
Stereotactic body radiotherapy and tyrosine kinase inhibitors in patients with oligometastatic renal cell carcinoma: a multi-institutional study, STRAHLENTHERAPIE UND ONKOLOGIE, 199(5), 2022
Prof. Dr. Hüseyin Cem Önal, Oymak E, Doç. Dr. Ozan Cem Güler, Tilki B, Yavas G, Hurmuz P, Yavas C, Öğr.Gör. Ebru Seyhun |